IRIS
FURNARI, MANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.980
Totale 9.980
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.980
Totale 9.980
Salva come PNG Salva come JPEG
Città #
Genova 7.131
Genoa 954
Vado Ligure 945
Rapallo 930
Bordighera 20
Totale 9.980
Salva come PNG Salva come JPEG
Nome #
The sensory system of the esophagus--what do we know? 176
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 169
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 154
Gastric and masticatory performances in full-arch immediate loading rehabilitated patients 152
Proton pump inhibitors: use and misuse in the clinical setting 152
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 149
Incidental physiological sliding hiatal hernia: a single center comparison study between CT with water enema and CT colonography 149
Advancements in the use of manometry and impedance testing for esophageal functional disorders 146
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 142
Barrett's esophagus in 2016: From pathophysiology to treatment 142
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 142
Measurement of oro-caecal transit time by magnetic resonance imaging. 136
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 134
A safety review of proton pump inhibitors to treat acid-related digestive diseases 133
Breath tests to assess alcoholic liver disease. 132
Caution About Overinterpretation of Number of Reflux Episodes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease 132
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 132
Comparison of computed tomography and magnetic resonance imaging in the discrimination of intraperitoneal and extraperitoneal rectal cancer: initial experience 131
Data on symptom association analysis in patients undergoing endoscopic therapy is useful to better define a successful therapeutic approach 125
Feasibility of the cut-and-push method for removing large caliber, soft, percutaneous endoscopic gastrostomy devices. 123
A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients 123
Microscopic Esophagitis, Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave in Functional Heartburn: Useful Diagnostic Tools. 123
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 122
Degree of colonic distension: intrapatient comparison between CT colonography and CT with water enema 122
Current treatment options for esophageal diseases. 121
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 121
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. 120
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 118
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 117
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 116
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 116
Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? 116
Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery 113
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin 113
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn 112
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 111
It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients. 110
Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: the perfect storm 110
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. 109
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 108
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 108
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 106
Harmonising proton pump inhibitors treatment in the specialist setting following the SIGE recommendations 106
Hepatocellular carcinoma is the most frequent final diagnosis of focal liver lesions identified in a cross-sectional evaluation of patients with chronic liver disease in Saudi Arabia. 105
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 104
The appropriate use of proton-pump inhibitors 104
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants. 104
Full-Dose Peginterferon Alfa-2a and Low-Dose Ribavirin Treatment of Genotypes 1 and 4 Chronic Hepatitis C Patients With End-Stage Renal Disease. 103
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease. 103
The natural history of gastro-esophageal reflux disease: A comprehensive review 103
Optimal management of constipation associated with irritable bowel syndrome. 102
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 102
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 101
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 98
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 97
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? 97
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 95
Sniffing out causes of gastrointestinal disorders: A review of volatile metabolomic biomarkers 95
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 93
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 93
NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis 92
Gastrointestinal motility disorder assessment in systemic sclerosis. 90
Gastrointestinal involvement in systemic sclerosis 90
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 90
Esophageal testing: What we have so far 89
Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time 88
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool. 87
Overweight is a risk factor for both erosive and non-erosive reflux disease. 86
Treatment of early stage chronic hepatitis C virus infection 85
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients 85
Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir 85
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 84
null 83
Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. 82
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered 82
Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. 78
Basal cell hyperplasia and dilatation of intercellular spaces are the main histologic features associated to the endoscopic/impedance-pH diagnosis of GERD and its related mucosal integrity impairment 78
Letter: Treatment for small intestinal bacterial overgrowth - Where are we now? 78
Hepatocellular Carcinoma Intermediate Stage Subclassification Systems: One, None, and One Hundred Thousand 77
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data 77
Polyp and endoscopist-related factors influencing complication rates in difficult colonic polypectomies: results of a multicenter observational study 76
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors. 75
Prevalence of active H. pylori infection and clarithromycin-contatining triple therapy efficacy in patients with dyspepsia-experience of a tertiary centre in North of Italy 74
M01822 Diagnostic accuracy and Inter/Intra-observer Agreement between endoscopists with different expertise, before and after a short training, for the detection of gastric intestinal metaplasia by means of narrow band imaging with magnifying endoscopy 74
Esophageal baseline impedance values correlate with presence and severity of microscopic esophagitis in patients with gastro-esophaeal reflux disease 74
Signet ring cell carcinoma of the stomach: correlation between endocytoscopy and histology 74
Course of oesophageal varices and performance of non-invasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease 73
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 72
Applicability of Parameters for the Non-Invasive Diagnosis of Esophageal Varices Needing Treatment to Cured HCV Patients 70
Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review 70
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. 60
Intra- and interobserver Agreement between endoscopists and pathologists for detection of gastric intestinal metaplasia by means of narrow band imaging with magnifying endoscopy 60
Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV 60
Risk factors for bleeding following oesophageal band ligation: Providing further evidence to ameliorate clinical practice 57
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective? 57
Presence of basal cell hyperplasia and dilatation of intercellular spaces and their association with baseline impedance values in patients with positive symptom association despite normal acid exposure further supports their role in symptoms generation in NERD 55
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study 46
Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? 45
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 38
Latest insights into the hot question of proton pump inhibitor safety – a narrative review 32
Totale 10.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.256
article - articoli 34.080
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 176
Totale 68.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.082 0 0 0 0 0 319 409 232 277 483 272 90
2020/20211.205 58 175 85 110 74 123 52 164 76 127 70 91
2021/20221.209 82 31 69 121 35 128 44 304 80 141 38 136
2022/20231.122 123 107 28 85 189 152 6 92 212 6 111 11
2023/2024708 34 96 10 92 70 116 55 28 23 24 46 114
2024/20251.071 100 144 99 159 301 268 0 0 0 0 0 0
Totale 10.458